Multiple Cancers in a Patient with Systemic Sclerosis and Aggravated Interstitial Lung Disease by Chemotherapy / 결핵및호흡기질환
Tuberculosis and Respiratory Diseases
; : 111-115, 2013.
Article
de En
| WPRIM
| ID: wpr-193684
Bibliothèque responsable:
WPRO
ABSTRACT
Although the relationship between malignancy risk with systemic sclerosis (SSc) has been inconclusive, there are some previous studies for a positive correlation. Most patients with SSc have some degree of lung parenchymal involvement in the form of interstitial thickening and fibrosis. Interstitial lung disease is the most common pulmonary manifestation of SSc. Interstitial lung disease following chemotherapy (5-fluorouracil, leucovorin, and oxaliplatin [FOLFOX]) is an uncommon life-threatening complication and it is induced by oxaliplatin. We report a case of multiple cancers in a patient with SSc and aggravated interstitial lung disease by chemotherapy.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Composés organiques du platine
/
Sclérodermie systémique
/
Fibrose
/
Leucovorine
/
Pneumopathies interstitielles
/
Poumon
/
Tumeurs du poumon
Limites du sujet:
Humans
langue:
En
Texte intégral:
Tuberculosis and Respiratory Diseases
Année:
2013
Type:
Article